Israel China (Israel) Today
| ICB Stock | 620.00 14.20 2.34% |
Performance3 of 100
| Odds Of DistressLess than 47
|
Israel China is trading at 620.00 as of the 22nd of November 2024, a 2.34 percent increase since the beginning of the trading day. The stock's open price was 605.8. Israel China has 47 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Israel China Biotechnology are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of April 2023 and ending today, the 22nd of November 2024. Click here to learn more.
Moving together with Israel Stock
Moving against Israel Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Israel Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Israel China's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Israel China or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Ideas | (View all Themes) |
| Business Concentration | Computers, IT, Biotech, Health Care Equipment & Supplies, Healthcare, Computing (View all Sectors) |
Israel China Biotechnology (ICB) is traded on Tel Aviv Stock Exchange in Israel and employs 4 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 19.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Israel China's market, we take the total number of its shares issued and multiply it by Israel China's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Israel China Biotech operates under Healthcare sector and is part of Health Care Equipment & Supplies industry. The entity has 3.75 M outstanding shares.
Israel China generates negative cash flow from operations
Check Israel China Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Israel China is USD19.47 Million. Israel China secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Israel Ownership Details
Israel China Biotech Risk Profiles
Although Israel China's alpha and beta are two of the key measurements used to evaluate Israel China's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.69 | |||
| Semi Deviation | 4.16 | |||
| Standard Deviation | 3.86 | |||
| Variance | 14.94 |
Israel Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Israel China without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Israel China Corporate Management
Elected by the shareholders, the Israel China's board of directors comprises two types of representatives: Israel China inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Israel. The board's role is to monitor Israel China's management team and ensure that shareholders' interests are well served. Israel China's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Israel China's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Qingxi Huang | Pres Chairman | Profile | |
| Pr Abboud | Chief Consultant | Profile | |
| Guy Goldin | Chief Officer | Profile | |
| Andrew Zhang | CEO Director | Profile | |
| Eitan Segal | Director Devel | Profile | |
| Amir Beker | Chief Inc | Profile | |
| Yehuda Bruner | Chief Officer | Profile |
Other Information on Investing in Israel Stock
Israel China financial ratios help investors to determine whether Israel Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Israel with respect to the benefits of owning Israel China security.